Form 4: Integra LifeSciences Director Barbara Hill Reports Acquisition of Shares
SEC Form 4 Filing
Director Barbara Hill reports acquiring shares of Integra LifeSciences Holdings Corp through non-open market transactions.
Summary
- On May 9, 2024, Barbara B Hill, a director of Integra LifeSciences Holdings Corp, reported acquiring 3,163 shares of common stock at $0 and 8,696 shares of common stock at $0.
- Following these transactions, Hill directly owns 100,322 shares of Integra LifeSciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing. The sentiment is neither positive nor negative.
Positives
- Increased insider ownership can sometimes be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as an indicator of management's view of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Date of the stock transactions. |
| 05/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.